Addressing the global threat
of antibiotic resistance

News

VenatoRx Pharmaceuticals Founders Christopher J. Burns, Ph.D., Luigi Xerri, Ph.D. and Daniel C. Pevear, Ph.D. named EY Entrepreneur Of The Year 2018 Finalists in the Greater Philadelphia Area
April 19, 2018
VenatoRx Pharmaceuticals to Present in vitro and in vivo data for cefepime/VNRX-5133 at ECCMID 2018
April 12, 2018
> See all Press Releases

Pipeline

VenatoRx Team